191 related articles for article (PubMed ID: 28039468)
1. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
Shiina M; Hashimoto Y; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Varahram S; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Tabatabai L; Deng G; Kumar D; Dahiya R
Oncotarget; 2017 Jan; 8(5):8356-8368. PubMed ID: 28039468
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans.
Shiina M; Hashimoto Y; Kulkarni P; Dasgupta P; Shahryari V; Yamamura S; Tanaka Y; Dahiya R
BMC Cancer; 2021 Sep; 21(1):1028. PubMed ID: 34525952
[TBL] [Abstract][Full Text] [Related]
3. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
[TBL] [Abstract][Full Text] [Related]
4. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.
Theodore SC; Davis M; Zhao F; Wang H; Chen D; Rhim J; Dean-Colomb W; Turner T; Ji W; Zeng G; Grizzle W; Yates C
Oncotarget; 2014 Jun; 5(11):3512-25. PubMed ID: 25004396
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
7. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
Chen W; Yao G; Zhou K
J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
[TBL] [Abstract][Full Text] [Related]
8. The role of miR-24 as a race related genetic factor in prostate cancer.
Hashimoto Y; Shiina M; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Shahryari V; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Deng G; Tabatabai L; Kumar D; Dahiya R
Oncotarget; 2017 Mar; 8(10):16581-16593. PubMed ID: 28157714
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer.
Ganapathy K; Staklinski S; Hasan MF; Ottman R; Andl T; Berglund AE; Park JY; Chakrabarti R
Sci Rep; 2020 Mar; 10(1):5167. PubMed ID: 32198489
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.
Hu SY; Liu T; Liu ZZ; Ledet E; Velasco-Gonzalez C; Mandal DM; Koochekpour S
Asian J Androl; 2010 May; 12(3):336-43. PubMed ID: 20173765
[TBL] [Abstract][Full Text] [Related]
11. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
12. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
13. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
15. miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.
Das DK; Naidoo M; Ilboudo A; Park JY; Ali T; Krampis K; Robinson BD; Osborne JR; Ogunwobi OO
Exp Cell Res; 2016 Nov; 348(2):190-200. PubMed ID: 27693493
[TBL] [Abstract][Full Text] [Related]
16. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H
Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614
[TBL] [Abstract][Full Text] [Related]
17. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
Sikand K; Slaibi JE; Singh R; Slane SD; Shukla GC
Int J Cancer; 2011 Aug; 129(4):810-9. PubMed ID: 21710544
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.
Gujrati H; Ha S; Waseem M; Wang BD
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077039
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.
Qu F; Cui X; Hong Y; Wang J; Li Y; Chen L; Liu Y; Gao Y; Xu D; Wang Q
Mol Cell Biochem; 2013 May; 377(1-2):121-30. PubMed ID: 23417242
[TBL] [Abstract][Full Text] [Related]
20. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
